Next Article in Journal
Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
Next Article in Special Issue
A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer
Previous Article in Journal
Photodegradation of Bexarotene and Its Implication for Cytotoxicity
Previous Article in Special Issue
Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(8), 1221; https://doi.org/10.3390/pharmaceutics13081221
Action Date Notes Link
article xml file uploaded 7 August 2021 12:41 CEST Original file -
article xml uploaded. 7 August 2021 12:41 CEST Update https://www.mdpi.com/1999-4923/13/8/1221/xml
article pdf uploaded. 7 August 2021 12:41 CEST Version of Record https://www.mdpi.com/1999-4923/13/8/1221/pdf
article supplementary file uploaded. 7 August 2021 12:41 CEST - https://www.mdpi.com/1999-4923/13/8/1221#supplementary
article html file updated 7 August 2021 12:42 CEST Original file -
article html file updated 27 July 2022 08:41 CEST Update https://www.mdpi.com/1999-4923/13/8/1221/html
Back to TopTop